poor feeding and respiratory distress in patients under the age of two years (2, 3). At a smaller percentage, other viruses such as adenovirus, parainfluenza and influenza viruses, rhinoviruses, human metapneumovirus, bocavirus or even atypical
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Acute bronchiolitis is a lower respiratory tract infection with respiratory syncytial virus (RSV) being the most common etiological factor of the disease, occurring in epidemics during cold months (I). It presents mainly with coughing, wheeze, bacterial pathogens as mycoplasma pneumoniae have been implicated as etiological agents of acute bronchiolitis (3) . Multiple infections are reported in 20-30% of children (3) .
Nearly all children are affected by RSV by the age of two years, but the infection is usually more severe between the ages of eight to thirty weeks (1) . Reported important risk factors for the development of severe RSV infection include prematurity, congenital heart or lung disease, congenital or acquired immunodeficiency, many siblings, child care attendance, exposure to tobacco smoke and lack of breastfeeding (4).
Many different types of cells contribute to host response in RSV infection (5) . Between all those cells there is a matrix of interactions that are regulated by cytokines and chemokines. Innate immunity is the first defence ofthe host against RSV and other viruses and its major role is to sense the pathogens and deflect the adaptive immunity into a THlITH2 response through secretion of cytokines and interaction with ligands (6) . The human Toll-like receptor (TLR) family has recently been indentified and was found to be a critical link between immune stimulants produced by microorganisms and the initiation of host defence (7) .
TLR4 is the primary signaling receptor for Gram-negative lipopolysaccharides (LPS). Although structurally unrelated to LPS, RSV fusion (F) membrane protein also triggers TLR4 and uses CDl4 as a co-receptor, so the structural complex ofTLR4/CDI4 participates in the virus recognition as a component of natural immune response (8, 9) . F protein connects to the TLR4/CDI4 complex and enhances its expression on the cell membrane. Infants with RSV bronchiolitis have presented with increased numbers of monocytes that carry TLR4 in peripheral blood (l0).
Considering the importance of the TLR4/CDI4 complex in initiating innate immunity to RSV, the aim of the study was to investigate the possible role of polymorphisms of TLR4 (Asp299Gly and Thr399I1e) and CD14 C-159T and C-550T in the development of RSV bronchiolitis.
MATERIALS AND METHODS
The study included two groups of children, a patient group and a control group. Informed consent was obtained from the parents or guardians of all children. The study protocol was approved by the University Ethics Committee.
The patient group consisted of 50 previously healthy infants and small children (27 boys and 23 girls) aged from 15 days to 2 years (median age 4.25 months) who were hospitalized with the diagnosis of acute bronchiolitis in a Pediatric Department in Northern Greece from September 2008 until May 2009. Diagnosis of acute bronchiolitis was based on patient history and clinical criteria. The main clinical symptoms of acute bronchiolitis include a prodrome of upper respiratory viral infection, such as nasal congestion, cough and usually non-toxic fever. After a couple of days from the appearance of the first symptoms, the child develops signs characteristic of respiratory distress such as tachypnoea, nasal flaring, chest wall retractions and wheezing. Respiratory distress usually leads to inadequate feeding and dehydration. Most children with respiratory distress signs present a decline in oxygen saturation (Sp02<96%):
Disease severity was accessed with the use of a clinical severity index based on heart rate, respiratory rate, wheezing, difficulty in feeding and oxygen saturation that was calculated upon admission (11) . The patients in our study had a severity score of moderate-to-severe disease that required hospitalization and oxygen supplementation. No patient needed admission to the PICU.
The control group consisted of 99 healthy children (66 boys and 33 girls), aged 4 to 14 years (median 7.34 years). Exclusion criteria for all study participants were chronic conditions involving the respiratory, cardiovascular or immune systems, gestational age :oS 36 weeks and prophylaxis for RSV (monoclonal antibodies). In addition, children from the control group had a past history free from serious or frequent respiratory infections and/or relapsing of wheezing episodes.
From all patients a nasopharyngeal swab was taken upon admission to identify respiratory viruses (RSV, Corona virus, HINI virus, adenovirus, bocavirus, influenza and parainfluenza viruses) by polymerase chain reaction (PCR).
A sample of whole blood with anticoagulant (EDTA) was taken for DNA extraction. Genomic DNA was isolated from whole peripheral blood according to the protocol ofthe manufacturer (Pure gene, DNA purification system, Gentra). The extraction product was frozen and stored at -20°C until being used for the identification of the TLR4 Asp299Gly (rs4986790) and Thr399Ile (rs4986791) as well as the CD14 C-159T (rs2569190) and C-550T (rs5744455) polymorphisms. The analysis of DNA samples was performed by the PCR-RFLPs method. 
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The primer sequences and thermal cycling conditions for genotyping of TLR4 and CD14 polymorphisms are outlined in Table 1 .
TLR4 genotyping
After PCR the products were digested with 3 units of Dpnl enzyme (New England Biolabs) (Asp299Gly) and 4 units ofMspl enzyme (New England Biolabs) (Thr399Ile) at 37°C overnight. Products were separated on a 2.5% agarose gel (Figs. 1 and 2).
CDJ4 genotyping
After PCR the products were digested with 3 units of AvaIII enzyme (New England Biolabs) (C-159T) and 3 units ofHaeIII enzyme (New England Biolabs) (C-550T) at 37°C overnight. Products were separated on a 2.5% agarose gel ( Figs. 3 and 4 ).
Statistical analysis of data was carried out using the statisticalprograms GenePop 4.0.10 Kat SPSS 16.Genotypes and allele frequencies in the case and control groups were analyzed and compared by performing Pearson's chitest. The contingency xl test was used to compare the demographic characteristics in the patients versus the control subjects. Mann-Whitney U test was used for the evaluation of the parameters that did not present normal distribution. The level of statistical significance was set to p <0.05. A Hardy-Weinberg test was performed and both sets of polymorphisms were tested for linkage equilibrium. 
RESULTS
Median age of the patients enrolled in the study was 4.25 months (range: 0.5-24 months) and the male to female ratio was 1.17:1. Comparing age among sexes in the patient group, no statistically significant difference was found (p=0.73). The control group consisted of 99 children aged 4 to 14 years old with median age of 7.34 years (range: 4-14 years), with male to female ratio 2: I. When comparing age among the two sexes in this group, no significant difference was found (p=0.81). The patient group was further divided according to the identification of RSV as the causative agent of acute bronchiolitis into RSV bronchiolitis and non-RSV bronchiolitis. The RSV bronchiolitis group consisted of27 patients, 15 boys and 12 girls, with a median age of 4 months (range: 0.5-24 months). The non-RSV bronciolitis group consisted of23 children, 13 boys and 10 girls with a median age of 5 months (range: 1-24 months). No significant difference was found (p=0.6l).
In the 27 patients with RSV bronchiolitis, we were able to identify RSV serotype (A or B). RSV-A serotype was found in 13 patients and RSV-B in 14 (p=0.17). Median age of patients with RSV-A bronchiolitis was 3.5 months (range: 1-10 months) and in patients with RSV-B bronchiolitis was 2.75 months (range: 2-24 months) (p=0.733).
Genotypes and allele frequencies of TLR4 and CD 14 polymorphisms were determined in all children (patient and control groups) and the results are presented in Table II as frequencies of the alleles and the genotypes of the polymorphic markers.
According to the results of the Hardy-Weinberg 1 test, our two study groups are in equilibrium . Nevertheless, no linkage disequilibrium was proven between the two loci of the TLR4 gene (p=0.6l), which did not allow the study of haplotypes for these two polymorphisms. On the contrary, linkage equilibrium was proven between the two CD14 loci. However, haplotype analysis showed no association between these CD14 polymorphisms and manifestation of bronchiolitis .
We identified two heterozygous AG (4%) and three homozygeous GG (6%) patients for the TLR4 polymorphism Asp299Gly in the patients group, while in the control group, one AG (0.99%) and 5 GG (4.95%) subjects were found. The difference was not statistically significant (p=0.59).
The results for the second TLR4 polymorphism studied, Thr399I1e, showed that in the patient group 12 children (24%) were heterozygous and 7 children homozygous TT (14%), while in the control group 35 CT subjects (35.35%) and 13 TT subjects (13.13%) were detected, respectively. The difference for the Thr399I1epolymorphism was not statistically significant (p=0.47).
As regards the analysis of the polymorphisms C-159T and C-550T of protein CD14, our results show that 16 patients (32%) were heterozygous CT and 21 (42%) homozygous TT while in the control group 46 subjects (47.92%) and 20 (20.83%) were identified as heterozygous CT and homozygous Tables III and IV show the results ofall genotypes and allele correlations between the two groups (patients and control) . According to these, TLR4 569 polymorphisms Asp299Gly and Thr399Ile showed no significant difference in bronchiolitis patients than in control group. This lack of significance seems to exist also for the C-550T CD14 polymorphism (Table III) . On the contrary, when studying the C-159T polymorphism of protein CD14, a statistically significant difference was found concerning both the allele (p=O.03) and the genotype frequencies (p=O.05).
In addition, when comparing only the patients with RSV bronchiolitis with the control group, no significant difference was found between the polymorphism and RSV bronchiolitis for all polymorphism, but only an indication that the C-159T CD 14 polymorphism is more frequent in the patient group compared to the control group (Table III) .
In this study the frequency of the four polymorphisms was also compared between children with RSV and non-RSV bronchiolitis and between children with RSVA and RSVB bronchiolitis, but no statistically significant difference was found.
DISCUSSION
We studied the role ofpolymorphisms Asp299Gly and Thr399Ile of TLR4 and C-159T and C-550T of protein CD14 in the pathogenesis of RSV bronchiolitis in infants. This is the first study in Greece that refers to the epidemiological recording of these four polymorphism frequencies and tries to correlate them with acute bronchiolitis and RSV infection.
According to the analysis of our results there does not seem to be any correlation between TLR4 polymorphisms Asp299Gly and Thr399Ile and the severity of RSV bronchiolitis or any correlation with age and sex. These results are consistent with the study of Paulus et al. (12) , who studied the Asp299Gly TLR4 polymorphisms and did not find any statistically significant difference in clinical severity. Previously, Erridge et al. (13) and van de Graaf et al. (14) , specified the production of cytokines from monocytes of peripheral blood of normal homozygotes (AA) and heterozygotes (AG) of TLR4 Asp299Gly polymorphisms after stimulation with LPS, and did not find any statistically significant difference. Douville et al. (15) assessed the role of TLR4 Asp299Gly and Thr399Ile on proand anti-inflammatory cytokine production by fresh peripheral blood mononuclear cells exposed to LPS or RSV and found no impact across a population of healthy randomly selected children. In a recently published study (16) investigating the association of the Gly299 allele with severe RSV in a Finnish population, the authors proposed that the risk of severe RSV infection may additionally depend on the interaction between individual TLR4 genotype and the particular RSV group causing bronchiolitis. During the period ofour study, both RSVAand RSVB were equally detected in the study population, but no statistically significant differences were detected in the frequency of the four polymorphisms.
Awomoyi et al. (17) have found higher incidence of genotypes and alleles both of Asp299Gly and Thr399Ile in high risk children for developing severe RSV infection (premature, congenital heart or lung defect) compared with mild bronchiolitis or control population. This finding is not in agreement with our results and we believe that this difference depends on the selection ofthe study population, as Awomoyi et al. studied high risk children who were excluded from our study.
There are also other studies in literature that contradict our results. More specifically, Puthothu et al. (18) , while studying children with bronchiolitis in Germany found a possible correlation between the Asp299Gly polymorphism and severe bronchiolitis. The polymorphism was found in higher incidence in the control group and has been thought to playa protective role in the development of severe infection. No correlation was found with polymorphism Thr399I1e alone, only while studying as a haplotype with polymorphism Asp299Gly. The different findings of this study may be explained as only patients with severe disease were enrolled which represent a different population.
Tal et al. (19) in Israel also found a correlation between the Asp299Gly and Thr399I1e polymorphisms and the development of severe bronchiolitis. Contrary to Puthothu et al. (18) , they found a higher incidence of homozygotes of these two polymorphisms in children with severe bronchiolitis compared with the control group.
In the present study, no linkage disequilibrium was proved between the two TLR4 polymorphisms, unlike the results of other studies. Specifically, according to present literature, the transmission of these two alleles (TLR4 Asp299Gly and Thr399I1e) across generations is not independent up to 98% in Caucasian people. On the contrary in a study held in West Africa a haplotype containing only the Asp299G1y polymorphism was found. Ferwerda et al. (20) studied 2,491 subjects from 15 different populations, representative of the African population before the immigration waves and also the variable immigration waves to Europe, Asia and America, in an effort to determine the distribution of these two TLR4 polymorphisms. In African populations Asp299Gly was found in 10-18%, while Thr399I1e in 2% of the population and always together with Asp299Gly. Hang et al. (21) in China and Inoue et al. (22) in Japan describe that in Asian and native American populations these two TLR4 polymorphisms have not been found at all or only in particular individuals. In Indo-European populations 6-14% of the total population, are heterozygotes for both polymorphisms. In our study, the percentage of healthy people carrying the polymorphisms was about 7.38% for the Asp299Gly polymorphism and 44.97% for the Thr399I1e polymorphism.
The most probable explanation of this disagreement between the present study and other studies is the genetic heterogeneity among the different nationalities (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) .
Cluster of differentiation 14 (CDI4) represents a family ofpattern recognition receptors with a crucial role in innate immunity. The CD14 gene is localized in chromosome 5q31.1, a region considered to be linked to asthma and atopy. Therefore, most published studies focus on the relationship of CD14 polymorphisms with the development of asthma rather than acute bronchiolitis.
In our study, the correlation found of the two CD14 polymorphisms C-159T and C-550T with bronchiolitis, highlights the presence ofa statistically significant difference in both the genotype (p=0.05) and the allele (p=0.04) frequency for the C-159T polymorphism. Nevertheless, no significant difference was found between the polymorphism and RSV bronchiolitis, but only an indication that the polymorphism is more frequent in the patient group compared to the control group. No correlation was found between the C-550T CD14 polymorphism and the severity of bronchiolitis.
Unlike the TLR4 polymorphisms, linkage disequilibrium was proven between the two CD14 loci. Nevertheless, haplotype analysis showed no association between these CD14 polymorphisms and manifestation of bronchiolitis.
Puthothu et al. (18) genotyped the CD14promoter polymorphism C-159T in a population of infants with severe RSV-associated disease and found no association of this polymorphism with susceptibility to RSV disease. In a recently published study of Jung et al. (23) , C-159T polymorphism was most commonly identified in children with a past history of bronchiolitis and considered a significant risk factor for future asthma. This finding supports the hypothesis that gene-environmental interactions, with an environmental factor as bronchiolitis, may playa role in a population of susceptible children.
In conclusion, according to the results of this study it is possible that protein CD14 has a functional role in the viral conjunction to the structural complex TLR4/CDI4. The correlation that was found between the C-159T polymorphism and the manifestation of bronchiolitis, in this study, points out that the severity in the development of the disease is not specified exclusively by the pathogen. It. seems that immune response of the host plays a significant role. For this reason, it is possible that the activation of the immunological mechanisms described is taking place during the invasion of other pathogens also and the development of bronchiolitis. More extensive multicentric studies are needed in order to lead to safer conclusions
